David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc. (APLS), sold 6,646 shares at $30.43 ($202K) on 2025-01-22, disclosed to the SEC on 2025-01-23.
Seasonal sale ($202k) by General Counsel — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.43 | 3,323 | $101K | 50.0% |
| 2 | $30.43 | 3,323 | $101K | 50.0% |
| Total | $30.43 avg | 6,646 | $202K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $128K | — | Filing → |
| APLS | SELL | 2025-12-18 | $245K | — | Filing → |
| APLS | SELL | 2025-11-18 | $100K | — | Filing → |